NEURELIS ANNOUNCES FDA APPROVAL FOR IMMEDIATE USE SEIZURE …
Apr 16, 2025 · Indication VALTOCO® (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive …
VALTOCO ® (Diazepam Nasal Spray) for the Acute Treatment of ...
Valtoco® is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age …
VALTOCO® (diazepam nasal spray) for Episodes of Frequent Seizures
VALTOCO is a prescription medicine used for short-term treatment of seizure clusters (also known as “episodes of frequent seizure activity” or “acute repetitive seizures”) that are different from a person’s …
Diazepam rectal gel - for acute repetitive seizure treatment in patients with epilepsy ages 2 years and older. Valtoco (diazepam nasal spray) - for acute repetitive seizure treatment in patients with …
Why treat quickly | VALTOCO® (diazepam nasal spray) CIV
VALTOCO® (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct …
NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY …
Dec 5, 2025 · The FDA has approved Neurelis' VALTOCO ® (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute …
FDA Approves Valtoco Nasal Spray for Seizure Clusters
Apr 25, 2025 · Neurelis, Inc., announced that the FDA has approved Valtoco (diazepam nasal spray) for short-term treatment of seizure clusters (also known as “acute repetitive seizures”) that are different …
Valtoco Nasal Spray for Seizure Clusters - WebMD
Jul 17, 2024 · Valtoco (diazepam nasal spray) is a prescription medicine for quick and effective treatment of seizure clusters, also known as acute repetitive seizures, in people with epilepsy.
NEURELIS ANNOUNCES FDA APPROVAL FOR IMMEDIATE USE SEIZURE …
Apr 16, 2025 · VALTOCO maintains orphan drug exclusivity for VALTOCO to treat episodes of frequent seizures SAN DIEGO, April 16, 2025 /PRNewswire/ -- Neurelis, Inc., today announced that the U.S. …
FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5
Apr 16, 2025 · The FDA has approved an expanded indication for diazepam nasal spray (Valtoco; Neurelis), now allowing its use in children ages 2 to 5 for the treatment of seizure clusters, also …